eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | ulcerative colitis |
| Symptom | C0376620|pouchitis |
| Sentences | 15 |
| PubMedID- 24108111 | Background: pouchitis may develop in patients with ulcerative colitis undergoing pouch surgery. |
| PubMedID- 23957603 | The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. |
| PubMedID- 25596721 | Fk506-binding protein 5 mrna levels in ileal mucosa are associated with pouchitis in patients with ulcerative colitis. |
| PubMedID- 22529959 | pouchitis occurs in 50% of patients with ulcerative colitis after undergoing ileal pouch anal anastomosis (ipaa) . |
| PubMedID- 23576088 | Rate and predictive factors of post-ipaa crohn's-like disease (with or without pouchitis) in patients with ulcerative colitis. |
| PubMedID- 24206373 | Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis - authors' reply. |
| PubMedID- 22857825 | Method: seven pouchitis patients (with ulcerative colitis) were studied. |
| PubMedID- 24206372 | Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. |
| PubMedID- 26052770 | This editorial discusses the role of serial measurements of fecal calprotectin or fecal lactoferrin for the early detection of pouchitis in patients with ulcerative colitis having undergone procto-colectomy with ileo-pouch-anal anastomosis. |
| PubMedID- 21274444 | The development of chronic pouchitis in a patient with ulcerative colitis and ipaa always raises the concern that the underlying disorder could be crohn's disease. |
| PubMedID- 21127981 | Surgical prophylaxis of pouchitis in ulcerative colitis. |
| PubMedID- 24713729 | It was found that the 10-year rate of pouchitis was 48% in patients with chronic ulcerative colitis, 49% in those with indeterminate colitis and 56% in patients with crohn’s disease. |
| PubMedID- 21243500 | Vsl#3, a mixture of four lactobacilli, three bifidum, and one streptococcus species, has shown beneficial effects on pouchitis in patients with ulcerative colitis (uc) . |
| PubMedID- 22254095 | However, clinical practice guidelines are now including a probiotic as an option for recurrent and relapsing antibiotic sensitive pouchitis and the use of probiotics in mild ulcerative colitis is provocative and suggests potential for benefit in select patients but concerns remain about proof from trials. |
| PubMedID- 21466487 | How to manage pouchitis in ulcerative colitis. |
Page: 1